Pharmaceutical and medical device industries are currently laboring to meet Drug Supply Chain Security Act (DSCSA) regularity compliance by an ever shifting, but always looming target date. For AbbVie and its longtime contractor, Cesar Anicua of Sterling Engineering, robotics help meet tight regulatory requirements, eliminate human error from the system and reduce the need for human touches in processing pharmaceuticals and their track & trace info-laden labels. 

You won’t want to miss Matt Reynolds’ interview with Sterling Engineering’s Cesar Anicua, who for a decade has contracted with AbbVie alongside pharma-specialist integrator ESS Technologies to optimize robotics operations in the highly regulated pharmaceutical and medical device industries. Integrating robots often appears to be overkill, but when the utmost in precision, accuracy, and repeatability are called for, accept no substitute. And the accuracy pays for itself with an ROI that includes virtual elimination of rework and scraps.